skin aging treatment by unani formulation.

Phase 2

• Conditions: Health Condition 1: L578- Other skin changes due to chronicexposure to nonionizing radiation

• Registration Number: CTRI/2021/01/030852
• Lead Sponsor: ational institute of unani medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Having fine lines, wrinkles, hyper pigmentation

2. Moderate to advance facial skin aging

3. No known medical condition

4. Subject must sign a written informed consent

Exclusion Criteria

1. Subjects who are taking any medication which interfere with the test result.

2. Having history of skin cancer, melanoma , lupus, psoriasis, connective tissue disease.

3. Pregnant or planning pregnancy during study period, lactating, had given birth during the previous 6 months.

4. Acute or chronic allergy or history of hypersensitivity to cosmetics.

5. Smokers, having psychiatric disorder , hormone related and GIT disease.

6. Uncontrolled metabolic illness (e.g. diabetes mellitus, hypertension).

7. Having any skin procedure in previous 6 months (dermabrasion, chemical peel, botulinum toxin type A injection).

8. Subjects using anti aging skin care products.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Hydration. <br/ ><br>2.Hyperpigmentation. <br/ ><br>3.Dullness and roughness. <br/ ><br>4.Coarse wrinkles.Timepoint: 2 month

Secondary Outcome Measures

Name	Time	Method
1.Fine lines. <br/ ><br>2.thickness. <br/ ><br>3.Lusture of skinTimepoint: 2 months